Acandis® ICAD Treatment System:
A uniquely streamlined solution
for safe and effective ICAD treatment.
Safe, efficient and catheter‑exchange‑free treatment
— for both elective and acute ICAD cases.
Discover how Acandis® delivers a streamlined, clinically proven approach to support physicians in treating one of the most challenging causes of ischaemic stroke.
Understanding ICAD and
Our Integrated Solution.
Intracranial atherosclerotic disease (ICAD) is one of the most important causes of ischaemic stroke worldwide. Because ICAD carries one of the highest risks of recurrent stroke, particularly within the first weeks after symptom onset, effective and timely treatment is essential.
When first‑line medication therapy is insufficient, endovascular treatment becomes necessary.
The Acandis® ICAD Treatment System offers an easy‑to‑use, safe and efficient solution, indicated for both elective and acute treatment scenarios. Thanks to its unique design, physicians can perform step‑by‑step PTA and stent implantation without changing catheters, simplifying workflows and saving valuable time.
Find out more about the dedicated products and the various treatment options they offer.
Strong on Its Own.
Game‑Changing in Combination.
The combination of the NeuroSpeed® PTA Balloon Catheter and the CREDO® | CREDO® heal Stent has been specifically engineered to address
the complex anatomical and procedural challenges of ICAD treatment.
The NeuroSpeed® PTA Balloon Catheter enables smooth, controlled PTA as the first step.
If stabilisation is required, the CREDO® | CREDO® heal Stent can be delivered directly through the same NeuroSpeed® PTA Balloon Catheter,
without a catheter exchange.
This unique concept represents the only bailout stenting system indicated for both elective and acute cases, reducing treatment risk through
easy handling and time savings.
NeuroSpeed PTA Balloon Catheter
NeuroSpeed® PTA Balloon Catheter
Over-the-wire catheter for PTA and stent implantation, with different configurations created to meet the demands of intracranial stenosis procedures.
CREDO Stent
Flexible, self-expanding lasercut stent deliverable through 0.0165’’ ID NeuroSpeed® PTA Balloon Catheter
CREDO heal Stent
Flexible, self-expanding lasercut stent with unique HEAL Technology deliverable through 0.0165’’ ID
NeuroSpeed® PTA Balloon Catheter
Clinical Experience with Acandis® ICAD Treatment System.
Initial degree of stenosis
80 % Pre Dilatation
NeuroSpeed® PTA Balloon Catheter
2.0 x 8 mm Inflation
Final degree of stenosis
~ 10 % Post Dilatation
Images by courtesy of Dr. Christian Löhr,
Klinikum Vest, Recklinghausen, Germany
Pre-Treatment:
Stenosis grade 75 %
Post-Treatment with CREDO® heal Stent:
Stenosis grade 0 %
Follow Up 70 days:
Stenosis grade 0 %
Images are courtesy of Dr. Hannes Nordmeyer,
radprax Solingen, St. Lukas hospital, Germany
Clinical Evidence that Builds Trust.
Our commitment to evidence-based safety and efficacy.
RECHRUT
This study evaluates the safety and efficacy of acute permanent stenting with the self‑expandable CREDO® heal Stent in patients with symptomatic intracranial stenosis after unsuccessful thrombectomy. By generating robust clinical evidence in one of the most challenging stroke scenarios, it will empower physicians with greater therapeutic confidence and potentially offer patients a renewed chance at improved outcomes when every minute matters.
ASSISTENT
This real-world registry was designed to collect comprehensive information on technical and clinical safety of the use of the CREDO® Stent together with the NeuroSpeed® PTA Balloon Catheter in clinical practice. By documenting everyday treatment outcomes, this study will provide physicians with meaningful evidence to support ICAD patient management.
ICARUS
Acandis® is proud to sponsor the ICARUS study, an international, multi-centre study comparing early intracranial stenting with continued stent-retriever or aspiration-based endovascular treatment for patients who experience recanalisation failure due to ICAD. This collaboration reflects our commitment to strengthening the clinical evidence that guides neurointerventional practice.
Here you can find publications and clinical studies on our products.
Continuous Learning.
Confident Treatment.
Better Outcomes.
At Acandis®, our commitment extends beyond providing innovative devices. We actively support physicians through hands‑on ICAD training, including:
- Dedicated ICAD Workshops
- Sizing Support and 3D Modelling for Case Preparation
- Case Support
As part of our ICAD program, we host recurring workshops
to help clinicians build confidence and stay at the forefront of best practices.

Want to participate?
Reach out to your Acandis® representative.
Interested?
Let's Talk.
If you want to discover how you and your patients can benefit from this unique treatment system, please contact your
Acandis® representative or our Clinical Support Team (clinical-support@acandis.com).





